Liposome-Based in Situ Antigen-Modification Strategy for “Universal” T-Cell-Receptor Engineered T Cell in Cancer Immunotherapy

0
47
Scientists established a novel “universal” T cell receptor (TCR)-T “artificial antigen expression” technique that involved the delivery of the antigen to tumor cells using DSPE-PEG-NY-ESO-1157-165 liposomes to express TCR-T-cell-specific recognition targets.
[MedComm]
Full Article